Sign in and upgrade to a paid plan to export price history as CSV.

Arvind Remedies ltd.

BSE: 531823
₹4.70
▼ -0.24 (-4.86%)
June 13, 2016 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
47/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-1.2
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 1 met
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.9%
Low 4.7000 · High 4.7000
1W return
-4.9%
Low 4.7000 · High 4.7000
1M return
-6.4%
Low 4.7000 · High 5.7300
52W return
-64.6%
Low 3.7800 · High 21.4900
Lifetime High ₹64.4500 (Sept. 8, 2014)
Lifetime Low ₹1.0400 (March 9, 2009)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
4.9
10D
4.9
20D
5.0
50D
6.5
100D
8.8
200D
12.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

4.70
Pivot
First resistance4.70
Second resistance4.70
Third resistance4.70
First support4.70
Second support4.70
Third support4.70
Day RSI39.5
Day MFI63.7
Day MACD-0.38
Day MACD signal-0.58

Beta

1M—
3M—
1Y1.41
3Y1.11

Price change analysis

↓ -6.4%
Over 1 Month
LowHigh
4.705.73
↑ 15.8%
Over 3 Months
LowHigh
3.785.73
↓ -25.0%
Over 6 Months
LowHigh
3.786.40
↓ -64.6%
Over 1 Year
LowHigh
3.7821.49
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Jun 2016
  • Promoter3.58%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 3.58% in Jun 2016 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
8 Apr 2015 SUPRIYA SANTOSH GOENKA Bulk Sell 350,000 23.4700 BSE
10 Nov 2014 MARINA DEALCOM PRIVATE LIMITED Bulk Sell 400,000 45.7500 BSE
16 Sep 2014 VLS FINANCE LIMITED Bulk Sell 350,000 51.0700 BSE
16 Sep 2014 V L S CAPITAL LIMITED Bulk Sell 500,000 51.8700 BSE
9 Sep 2014 GKN SECURITIES Bulk Buy 363,713 60.4500 BSE
9 Sep 2014 GKN SECURITIES Bulk Sell 363,713 60.3200 BSE
8 Sep 2014 GKN SECURITIES Bulk Buy 536,395 63.4800 BSE
8 Sep 2014 GKN SECURITIES Bulk Sell 536,395 63.0400 BSE
8 Sep 2014 MARINA DEALCOM PRIVATE LIMITED Bulk Sell 905,534 63.8400 BSE
5 Sep 2014 GKN SECURITIES Bulk Buy 380,075 54.8600 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
24 Sep 2014 Annual General Meeting / Dividend - Re 0.80/- Per Share 0.8000 —
17 Sep 2013 Annual General Meeting/Final Dividend Re.0.80 Per Share And Special Dividend Re.0.20 Per Share (Bc Dates Revised) 0.8000 —
7 Sep 2012 Annual General Meeting And Dividend Re.0.70 Per Share (Bc Dates Revised) 0.7000 —

Corporate Actions

Full history (4 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
12 Apr 2016OTHER Annual General Meeting

All corporate actions →

Corporate Announcements

All 75 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
26 Jul 2018 Delisting Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the Arvind Remedies Limited w.e.f. August 08, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009.
28 Feb 2018 Public Notice - Compulsory Delisting Members of the Exchange are hereby informed that the Exchange on February 28, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).
17 Aug 2016 Appointment Arvind Remedies Limited has informed the Exchange that the decision to appoint Dr. Timothy and Mr. M Vasudevan as Additional Directors of the Company in view of the investment by M/s. Global Allied pharmaceuticals LLC.However, since the investment did not take place, the appointments were not effected.Further, the Directors information on the company from the company site the names of the above persons as directors, and in view of the above, .
17 Aug 2016 Financial Result Updates Arvind Remedies Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.
17 Aug 2016 Outcome of Board Meeting Arvind Remedies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 12, 2016, decided to defer all other items, intimated vide Company's letter dated August 02, 2016 to the next meeting.
30 May 2016 Disclosure under SEBI Takeover Regulations Dr B Arvind Shah has submitted to the Exchange vide letter dated May 25, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
26 May 2016 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Dr B Arvind Shah has submitted to the Exchange vide letter dated May 13, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
1 Apr 2016 AGM/Book Closure Arvind Remedies Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from April 15, 2016 to April 18, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on April 18, 2016.
30 Dec 2015 Extension of Annual General Meeting Arvind Remedies Limited has informed the Exchange that the company has obtained further extension upto March 2016 to hold the Annual General Meeting for the financial year ended June 30, 2015. A copy of the approval dated December 23, 2015 received from the Registrar of Companies is enclosed.
27 Nov 2015 Outcome of Board Meeting Arvind Remedies Limited has informed the Exchange that the Board Meeting held on November 26, 2015 has discussed in detail reasons for the delay, the financial constraints through which the company is passing through, and the restructuring request with the banks through investor by SDR route for which negotiations are going on. Board felt that instead of considering unaudited results for the quarters ended March 31, 2015 and June 30, 2015 to avoid the notice of suspension, since the audit is going on, it is advisable to come out with the audited results for these quarters, along with the unaudited financial results for the quarter ended September 30, 2015. After considering the status of audit, it was decided that next Board meeting be convened on December 10, 2015.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 64.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Arvind Remedies ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.